Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
5 hedge funds and large institutions have $310K invested in Bionano Genomics, Inc. Warrant in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
44% more capital invested
Capital invested by funds: $216K → $310K (+$94K)
25% more funds holding
Funds holding: 4 → 5 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$157 |
BNGOW Hedge Fund Activity: Q1 2019 in Review
5 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q1 2019, worth a combined $310K — up 44% from $216K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BNGOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Worth Venture Partners, opening a new position worth an estimated $141K. The largest seller was UBS Group, cutting an estimated $157.
- 5 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q1 2019, up from 4 in Q4 2018.
- Funds reported $310K of Bionano Genomics, Inc. Warrant stock for Q1 2019, up 44% quarter-over-quarter.
- 1 fund opened new Bionano Genomics, Inc. Warrant positions in Q1 2019 and 0 closed out, a net change of +1 holder.
- The largest Bionano Genomics, Inc. Warrant buyer in Q1 2019 was Worth Venture Partners, an estimated $141K added.
- The largest Bionano Genomics, Inc. Warrant seller in Q1 2019 was UBS Group, an estimated $157 sold.
Based on aggregated 13F filings for Q1 2019.